Dollvet joins East Africa’s Foot-and-Mouth Disease Vaccine Project

Author: Staff WriterPublished on: November 19, 2026Country: Tanzania
HealthScienceWorld / International
Dollvet joins East Africa’s Foot-and-Mouth Disease Vaccine Project

In November 2026, Turkish veterinary vaccine manufacturer Dollvet joined the AgResults project for foot-and-mouth disease vaccines in Eastern Africa. After registering a quadrivalent vaccine in Ethiopia that meets the project’s Target Product Profile and securing approval from its Judging Panel, Dollvet entered the vaccine distribution cost-share phase. It joins Biopharma and Boehringer Ingelheim, which entered the competition in 2025 and 2026, respectively. Launched in 2020 with a US$17.34 million prize fund, the project aims to develop and distribute high-quality vaccines suited to the region.

Read original article

tanzaniatimes.net

Stay informed with NewsBoulevard

Get the latest news summaries delivered to your inbox

Related News

Stay Updated with NewsBoulevard

Subscribe to our newsletter for the latest news summaries delivered to your inbox